Cite
Safety of the Bacillus thuringiensis-derived Cry1A.105 protein: Evidence that domain exchange preserves mode of action and safety.
MLA
Wang, Cunxi, et al. “Safety of the Bacillus Thuringiensis-Derived Cry1A.105 Protein: Evidence That Domain Exchange Preserves Mode of Action and Safety.” Regulatory Toxicology & Pharmacology: RTP, vol. 99, Nov. 2018, pp. 50–60. EBSCOhost, https://doi.org/10.1016/j.yrtph.2018.09.003.
APA
Wang, C., Li, W., Kessenich, C. R., Petrick, J. S., Rydel, T. J., Sturman, E. J., Lee, T. C., Glenn, K. C., & Edrington, T. C. (2018). Safety of the Bacillus thuringiensis-derived Cry1A.105 protein: Evidence that domain exchange preserves mode of action and safety. Regulatory Toxicology & Pharmacology: RTP, 99, 50–60. https://doi.org/10.1016/j.yrtph.2018.09.003
Chicago
Wang, Cunxi, Wenze Li, Colton R. Kessenich, Jay S. Petrick, Timothy J. Rydel, Eric J. Sturman, Thomas C. Lee, Kevin C. Glenn, and Thomas C. Edrington. 2018. “Safety of the Bacillus Thuringiensis-Derived Cry1A.105 Protein: Evidence That Domain Exchange Preserves Mode of Action and Safety.” Regulatory Toxicology & Pharmacology: RTP 99 (November): 50–60. doi:10.1016/j.yrtph.2018.09.003.